A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The research was conducted within ...

In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive Planetary Health", scientists from the University of Vienna, in collaboration ...

Parkinson’s drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of potentially harmful bacteria like E. coli, reports a new study. The findings mean that ...

Alembic has received the Food and Drug Administration’s permission for entacapone tablets in a dosage strength of 200 mg. The product is the generic of Orion’s Comtan. The drug is indicated as an ...

In a groundbreaking new study scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The ...

Chemical imaging of active gut microbes. After brief incubation with heavy water, culture medium and a drug, various chemical bonds (here C-D and C-H) in the stool sample are shown in yellow and green ...